Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Nuffield Department of Women's & Reproductive Health DPhil student Josephine Agyeman-Duah on being named winner of PhD Student of the Year at the Postgrad Awards 2022.

Josephine Agyeman-Duah holding Postgrad Awards PhD Student of the Year award

The award recognises the individual PhD student who has become an excellent and inquisitive researcher, who is an integral part of their research group, someone who encourages and supports more junior members of the team, and works alongside the research community more widely.

Josephine Agyeman-Duah works in the department's INTERGROWTH-21ST research group - an International Fetal and Newborn Growth Consortium dedicated to improving perinatal health through the development of new fetal and newborn growth standards, providing tools for the continuity of care from conception to 5 years of age.  Her research focusses on neurodevelopmental assessment at age 2 for all children born preterm. 

Read the full story on the Nuffield Department of Women's and Reproductive Health website

Sasi Shanmugam Senga holding certificate of Highly Commended PhD Student of the YearCongratulations also to Sasi Shanmugam Senga, DPhil student in Ludwig Cancer Research Oxford (Nuffield Department of Medicine), on being highly commended by the judges in the PhD Student of the Year category.

Similar stories

New heart disease calculator could save lives by identifying high-risk patients missed by current tools

Collaborative research, led by the Nuffield Department of Primary Care Health Sciences (NDPCHS) and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, like heart disease and stroke, particularly identifying high-risk patients that current prediction tools miss.